- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2017
- Public Summary Document (PSD) July 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2017 PBAC Meeting - Word
Baricitinib – July 2017
Baricitinib, Tablet 2 mg, Tablet 4 mg, Olumiant®
Last updated
29 January 2018